共 86 条
[1]
Aguayo Bonniard A(2016)Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK) Expert Opin Drug Metab Toxicol 12 1279-1289
[2]
Yeung JY(2017)Ocular surface disease in patients under topical treatment for glaucoma Eur J Ophthalmol 27 694-704
[3]
Chan CC(2013)Glaucoma therapy and ocular surface disease: current literature and recommendations Curr Opin Ophthalmol 24 136-143
[4]
Birt CM(2004)Autologous serum eye drops for ocular surface disorders Br J Ophthalmol 88 1467-1474
[5]
Perez-Bartolome F(2018)The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summary Eye 32 44-48
[6]
Martinez-de-la-Casa JM(2018)Effects of 20% human serum on corneal epithelial toxicity induced by benzalkonium chloride: in vitro and clinical studies Cornea 37 617-623
[7]
Arriola-Villalobos P(1995)Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes CLAO J 21 221-232
[8]
Fernandez-Perez C(2018)Matrix metalloproteinase 9 point-of-care immunoassay result predicts response to topical cyclosporine treatment in dry eye disease Transl Vis Sci Technol 7 31-216
[9]
Polo V(2013)The practical detection of mmp-9 diagnoses ocular surface disease and may help prevent its complications Cornea 32 211-448
[10]
Garcia-Feijoo J(2012)Identification of the HSPB4/TLR2/NF-kappaB axis in macrophage as a therapeutic target for sterile inflammation of the cornea EMBO Mol Med 4 435-1802